Title of publication/presentation Journal name or audience of presentation (if oral) Expected date Title of publication/presentation Journal name or audience of presentation (if oral) Expected date Future Disclosures 3.3 Please keep your OTC Licensing Specialist informed of any future submission or acceptance for publication or other possible non-confidential disclosure of any manuscript(s), abstract(s) or oral presentation(s) describing the invention—such activities can adversely affect patent rights. Background Information 3.4 Are laboratory records and data available? Give reference numbers and physical location, but do not enclose documentation. 3.5 Are related patents known to the inventor? List below: 3.6 List most relevant articles, journals, or abstracts of other authors. 3.7 Are the inventors aware of any other university patents or potentially patentable inventions developed at the university or under development at the university that may be required to practice the invention disclosed herein? (check one) [ ]Yes [ ]No If Yes, please identify and explain: Section 4 – Financial Resources Obligations 4.1 Was the development of this intellectual property supported by a grant or contract? (check one) [ ]Yes [ ]No If Yes, please list below. If No, please explain why you believe this research result is outside any existing sponsored research: Note: of sponsors include but are not limited to, NIH, other federal agencies, state agencies, non-profit research foundations, and private companies. Gift contributions need not be listed. (Copy this block to list additional sponsors.) Name of sponsor: Title of project: UT Austin acct #: Grant #: Is UT acting as subcontractor? [ ]Yes [ ]No If Yes, identify prime contractor: Name of sponsor: Title of project: UT Austin acct #: Grant #: Is UT acting as subcontractor? [ ]Yes [ ]No If Yes, identify prime contractor:
Title of publication/presentation Journal name or audience of presentation (if oral) Expected date Title of publication/presentation Journal name or audience of presentation (if oral) Expected date Future Disclosures 3.3 Please keep your OTC Licensing Specialist informed of any future submission or acceptance for publication or other possible non-confidential disclosure of any manuscript(s), abstract(s) or oral presentation(s) describing the invention—such activities can adversely affect patent rights. Background Information 3.4 Are laboratory records and data available? Give reference numbers and physical location, but do not enclose documentation. 3.5 Are related patents known to the inventor? List below: 3.6 List most relevant articles, journals, or abstracts of other authors. 3.7 Are the inventors aware of any other university patents or potentially patentable inventions developed at the university or under development at the university that may be required to practice the invention disclosed herein? (check one) [ ]Yes [ ]No If Yes, please identify and explain: Section 4 – Financial Resources Obligations 4.1 Was the development of this intellectual property supported by a grant or contract? (check one) [ ]Yes [ ]No If Yes, please list below. If No, please explain why you believe this research result is outside any existing sponsored research: Note: of sponsors include but are not limited to, NIH, other federal agencies, state agencies, non-profit research foundations, and private companies. Gift contributions need not be listed. (Copy this block to list additional sponsors.) Name of sponsor: Title of project: UT Austin acct #: Grant #: Is UT acting as subcontractor? [ ]Yes [ ]No If Yes, identify prime contractor: Name of sponsor: Title of project: UT Austin acct #: Grant #: Is UT acting as subcontractor? [ ]Yes [ ]No If Yes, identify prime contractor:
Disclosure_BioSci_20160804.docx